XML 29 R35.htm IDEA: XBRL DOCUMENT v3.2.0.727
Debt and Warrants (Details)
1 Months Ended 2 Months Ended 3 Months Ended 12 Months Ended 15 Months Ended
Dec. 23, 2014
USD ($)
item
$ / shares
shares
Dec. 03, 2014
USD ($)
$ / shares
Oct. 30, 2014
USD ($)
item
Jul. 16, 2014
USD ($)
$ / shares
shares
Jun. 26, 2014
USD ($)
$ / shares
shares
Jun. 26, 2014
USD ($)
$ / shares
shares
Jun. 02, 2014
USD ($)
item
$ / shares
shares
May. 31, 2015
USD ($)
shares
Mar. 31, 2015
USD ($)
$ / shares
shares
Feb. 28, 2015
USD ($)
item
Aug. 31, 2014
USD ($)
$ / shares
shares
Feb. 28, 2014
USD ($)
$ / shares
shares
Feb. 28, 2014
USD ($)
$ / shares
Mar. 31, 2015
USD ($)
$ / shares
shares
Sep. 30, 2013
USD ($)
item
shares
Dec. 31, 2014
USD ($)
shares
Mar. 31, 2015
USD ($)
$ / shares
shares
May. 13, 2015
$ / shares
Convertible Promissory Notes and Common Stock Warrants                                    
Gross aggregate proceeds                           $ 250,000        
Exercise price (in dollars per share) | $ / shares                     $ 6.40              
Strike price (in dollars per share) | $ / shares                     $ 8.00              
Volatility (as a percent)                     52.00%              
Dividend yield (as a percent)                     0.00%              
Risk-free interest rate (as a percent)                     0.52%              
Net amount of Notes                 $ 786,150         $ 786,150   $ 424,674 [1] $ 786,150  
Transfer Agreement | Manufacturer                                    
Convertible Promissory Notes and Common Stock Warrants                                    
Number of warrants issued to purchase shares of common stock (in shares) | shares         16,666 16,666                        
Exercise price (in dollars per share) | $ / shares                 $ 6.30         $ 6.30     $ 6.30  
Exercise price as a percentage of initial public offering price         90.00% 90.00%                        
Series A redeemable convertible preferred stock                                    
Convertible Promissory Notes and Common Stock Warrants                                    
Issuance of convertible preferred stock (in shares) | shares                       2,224,991       3,015,902    
Original issue price (in dollars per share) | $ / shares                       $ 2.2472 $ 2.2472          
Warrants | Transfer Agreement | Manufacturer                                    
Convertible Promissory Notes and Common Stock Warrants                                    
Exercise price (in dollars per share) | $ / shares                 6.30         6.30     6.30  
Term         5 years                          
Warrants | Common Stock | Transfer Agreement | Manufacturer                                    
Convertible Promissory Notes and Common Stock Warrants                                    
Number of warrants issued to purchase shares of common stock (in shares) | shares         16,666 16,666                        
Exercise price (in dollars per share) | $ / shares         $ 4.35 $ 4.35                        
Fair value of warrants         $ 37,840 $ 37,840                        
Strike price (in dollars per share) | $ / shares         $ 4.83 $ 4.83                        
Term           5 years                        
Volatility (as a percent)         49.00%                          
Dividend yield (as a percent)         0.00%                          
Risk-free interest rate (as a percent)         1.64%                          
Exercise price as a percentage of initial public offering price         90.00% 90.00%                        
Standby bridge financing agreement                                    
Convertible Promissory Notes and Common Stock Warrants                                    
Exercise price (in dollars per share) | $ / shares   $ 5.23                                
Fair value of warrants   $ 505,348                                
Strike price (in dollars per share) | $ / shares   $ 5.01                                
Term   5 years 6 months                              
Volatility (as a percent)   63.00%                                
Dividend yield (as a percent)   0.00%                                
Risk-free interest rate (as a percent)   1.61%                                
Aggregate principal amount of bridge financing     $ 1,000,000                              
Debt discount     $ 605,348                              
Number of lenders | item     2                              
Standby bridge financing agreement | IPO                                    
Convertible Promissory Notes and Common Stock Warrants                                    
Exercise price (in dollars per share) | $ / shares                 $ 5.60         $ 5.60     $ 5.60  
Standby bridge financing agreement | Subsequent event                                    
Convertible Promissory Notes and Common Stock Warrants                                    
Interest Paid               $ 321,600                    
Standby bridge financing agreement | Interest Expense.                                    
Convertible Promissory Notes and Common Stock Warrants                                    
Term     6 months                              
Debt discount     $ 100,000                              
Amortization of debt discount                 $ 305,272                  
Additional financing costs     $ 104,000           49,555         $ 49,555     $ 49,555  
Standby bridge financing agreement | Scenario, Forecast                                    
Convertible Promissory Notes and Common Stock Warrants                                    
Exercise price as a percentage of initial public offering price     80.00%                              
Value to be divided by IPO exercise price to determine number of warrants granted                 $ 1,000,000         $ 1,000,000     $ 1,000,000  
Convertible promissory notes                                    
Convertible Promissory Notes and Common Stock Warrants                                    
Number of convertible promissory notes issued | item                             4      
Number of Accredited Investors | item                   2                
Gross aggregate proceeds                             $ 525,000      
Interest rate (as a percent)                             8.00%      
Number of business days after the date of consummation of the initial closing of a first equity round of financing, when the debt instrument is due                             10 days      
Pre-money valuation threshold amount                             $ 3,000,000      
Aggregate principal amount                   $ 250,000                
Amortization of debt discount                       $ 4,071 $ 1,443          
Net amount of Notes                             518,105      
Number of shares issued for notes converted | shares                       207,664            
Principal and interest paid on debt               103,912                    
Retirement of convertible promissory notes               $ (100,000)                    
Convertible promissory notes | Interest Expense.                                    
Convertible Promissory Notes and Common Stock Warrants                                    
Debt discount                             $ 6,895      
Convertible promissory notes | Dechra Pharmaceuticals PLC                                    
Convertible Promissory Notes and Common Stock Warrants                                    
Interest rate (as a percent)                 12.00%         12.00%     12.00%  
Number of warrants issued to purchase shares of common stock (in shares) | shares                 89,285         89,285     89,285  
Exercise price (in dollars per share) | $ / shares                 $ 5.60         $ 5.60     $ 5.60  
Investment Warrants Expiration Date                 Dec. 31, 2017                  
Aggregate principal amount                 $ 1,000,000         $ 1,000,000     $ 1,000,000  
Convertible promissory notes | Dechra Pharmaceuticals PLC | IPO                                    
Convertible Promissory Notes and Common Stock Warrants                                    
Exercise price (in dollars per share) | $ / shares                                   $ 5.60
Convertible promissory notes | Dechra Pharmaceuticals PLC | Scenario, Forecast                                    
Convertible Promissory Notes and Common Stock Warrants                                    
Number of shares issued for notes converted | shares               178,571                    
Convertible promissory notes | Warrants | Common Stock                                    
Convertible Promissory Notes and Common Stock Warrants                                    
Number of warrants issued to purchase shares of common stock (in shares) | shares                             207,664      
Warrant term                             5 years      
Exercise price as a percentage of purchase price paid by equity investors when pre-money valuation threshold amount is achieved                             75.00%      
Exercise price as a percentage of purchase price paid by equity investors                       75.00%            
Minimum pre-money valuation amount                       $ 3,000,000 $ 3,000,000          
Exercise price (in dollars per share) | $ / shares                       $ 2.5281 $ 2.5281          
Fair value of warrants                       $ 6,895 $ 6,895          
Strike price (in dollars per share) | $ / shares                       $ 2.5281 $ 2.5281          
Term                       5 years            
Volatility (as a percent)                       64.00%            
Dividend yield (as a percent)                       0.00%            
Risk-free interest rate (as a percent)                       1.82%            
Convertible note purchase agreement                                    
Convertible Promissory Notes and Common Stock Warrants                                    
Number of Accredited Investors | item 3           2                      
Gross aggregate proceeds $ 650,000                                  
Interest rate (as a percent) 12.00%     3.00%     3.00%                      
Number of business days after the date of consummation of the initial closing of a first equity round of financing, when the debt instrument is due 30 days                                  
Number of warrants issued to purchase shares of common stock (in shares) | shares 58,035                                  
Exercise price (in dollars per share) | $ / shares $ 4.15               $ 5.60         $ 5.60     $ 5.60  
Fair value of warrants $ 147,943                                  
Strike price (in dollars per share) | $ / shares $ 4.59                                  
Conversion price (in dollars per share) | $ / shares       $ 5.60     $ 5.60                      
Volatility (as a percent) 49.00%                                  
Dividend yield (as a percent) 0.00%                                  
Risk-free interest rate (as a percent) 1.10%                                  
Aggregate principal amount       $ 150,000     $ 300,000                      
Amortization of debt discount                           $ 60,528        
Number of shares issued for notes converted | shares       26,785     53,571                      
Aggregate principal amount issued to board member to which Series A preferred stock was sold $ 250,000           $ 200,000                      
Beneficial conversion feature $ 502,057     $ 37,500     75,000                      
Convertible note purchase agreement | IPO                                    
Convertible Promissory Notes and Common Stock Warrants                                    
Strike price (in dollars per share) | $ / shares                 5.60         $ 5.60     5.60  
Number of shares issued for notes converted | shares 116,070                                  
Exercise price as a percentage of initial public offering price 80.00%                                  
Convertible note purchase agreement | Interest Expense.                                    
Convertible Promissory Notes and Common Stock Warrants                                    
Amortization of debt discount                           $ 10,614        
Beneficial conversion feature             $ 18,720             $ 208,220        
Line of credit and loan agreement                                    
Convertible Promissory Notes and Common Stock Warrants                                    
Number of warrants issued to purchase shares of common stock (in shares) | shares                     33,333              
Exercise price (in dollars per share) | $ / shares                 $ 5.60         $ 5.60     $ 5.60  
Fair value of warrants                     $ 114,300              
Term                     2 years              
Exercise price as a percentage of initial public offering price                     80.00%              
Drawdown amount                                 $ 0  
Line of credit and loan agreement | Maximum                                    
Convertible Promissory Notes and Common Stock Warrants                                    
Stand-by line of credit                     $ 1,000,000              
[1] The condensed balance sheet at December 31, 2014 is derived from the audited financial statements at that date included in the Company's prospectus filed with the Securities and Exchange Commission pursuant to rule 424 (b)(4)on May 14, 2015.